Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection
The case for simplifying and using absolute targets for viral hepatitis elimination goals
Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: results from a multi-ethnic Asian cohort
Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B
Alcoholic Liver Disease
